Source: WebWire

Press Release: Sight Diagnostics : Sight Diagnostics Named to CNBC Disruptor 50 List After Year of Tremendous Momentum in Scaling its AI-Powered Sight OLO Blood Analyzer

New York, NY -- May 25, 2021 -- Sight Diagnostics Ⓡ, the company delivering lab-grade Complete Blood Count (CBC) results in minutes, announced today it has been named to the CNBC Disruptor 50, an annual list of forward-thinking and fast-growing private companies whose innovations are changing the world. This award comes in the same month that the company was recognized in the health category of Fast Company 2021 World Changing Ideas awards as well as in the 2021 Medical Design Ex...Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=274400

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Yossi Pollak's photo - Co-Founder & CEO of Sight Diagnostics

Co-Founder & CEO

Yossi Pollak

CEO Approval Rating

89/100

Read more